Background Infection is the most important cause of treatment-related morbidity and
mortality in pediatric patients treated for acute lymphoblastic leukemia (ALL). Although …

Background Bacterial infections are common during induction therapy in children and
adolescents with acute leukaemia and may cause infection-related mortality. Aim To …

Background Pediatric patients receiving induction chemotherapy for newly diagnosed acute
lymphoblastic leukemia (ALL) are at high risk of developing life‐threatening infections. We …

Importance Bacteremia causes considerable morbidity among children with acute leukemia
and those undergoing hematopoietic stem cell transplantation (HSCT). There are limited …

Objectives Toxic death is a big problem in the treatment of childhood acute lymphoblastic
leukemia (ALL), especially in low-income countries. Studies of ciprofloxacin as single agent …

Background Bacteremias are frequent during induction therapy for acute lymphoblastic
leukemia (ALL) in children. Antibacterial prophylaxis therapy may thus be warranted. The …

Background Infections are a major cause of morbidity and mortality in childhood acute
lymphoblastic leukemia (ALL) and only limited information is available on infectious …

Background We hypothesized that prophylactic administration of an appropriate antibiotic
following each delayed intensification (DI) in children with acute lymphoblastic leukemia …

Background Comprehensive studies on neutropenia and infection-related complications in
patients with acute lymphoblastic leukemia (ALL) are lacking. Patients and methods We …

BACKGROUND Intensive chemotherapy for pediatric acute myeloid leukemia incurs the risk
of infectious complications, but the benefits of antibiotic prophylaxis remain unclear …